news

according to the ai ​​express of meijing, on the evening of september 6, hunan jingfeng pharmaceutical co., ltd. (*st jingfeng, 000908.sz) issued a special risk warning announcement. the company's net assets at the end of the audit period in 2023 were negative, and the company's stock was subject to a delisting risk warning. as of june 30, 2024, the company's net assets attributable to shareholders of listed companies were -73.3085 million yuan, and the impact of the matters involved in the company's 2023 financial report audit report's qualified opinion and the negative opinion of the internal control report has not been completely eliminated. therefore, the company's 2024 financial accounting report and financial report internal control situation still have the risk of being issued a non-standard audit opinion, and the company still has the risk that the net assets at the end of 2024 may be negative. if the 2024 annual report is disclosed and touches the relevant circumstances stipulated in article 9.3.12 of the "shenzhen stock exchange stock listing rules", the company's stock will be decided by the shenzhen stock exchange to terminate its listing. the company has entered the pre-reorganization procedure, and there is still uncertainty as to whether the company can enter the reorganization procedure.

daily economic news